The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 599.00
Bid: 599.00
Ask: 599.20
Change: 2.00 (0.34%)
Spread: 0.20 (0.033%)
Open: 596.80
High: 599.20
Low: 596.00
Prev. Close: 597.00
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue & Allotment of Shares & Total Voting Rights

25 Mar 2024 11:54

RNS Number : 1719I
Darktrace PLC
25 March 2024
 

25 March 2024

 

Darktrace plc

("Darktrace")

 

Issue and allotment of Shares and Total Voting Rights

Darktrace announces the issue and allotment of shares pursuant to vesting of certain awards. Darktrace has issued and allotted an aggregate of 14,809 new ordinary shares of £0.01 each in Darktrace (the "New Shares"). An application has been made for the New Shares to be admitted to the Premium Listing Segment of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange.

The New Shares will rank pari passu in all respects with Darktrace's existing ordinary shares of £0.01 nominal value each ("Ordinary Shares"). It is expected that admission will become effective on 26 March 2024.

As a result of the 14,809 New Shares issued, the total number of Ordinary Shares outstanding as at 26 March 2024 will be 703,683,540. Each Ordinary Share carries the right to one vote. Darktrace has 3,323,886 Ordinary Shares as treasury shares with no voting rights. Therefore as at the close of business on 26 March 2024 the total voting rights figure of 700,359,654 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Darktrace under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules

 

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

luk.janssens@darktrace.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQKPBPDBKDNNB
Date   Source Headline
8th Sep 20234:57 pmRNSDirector Declaration
6th Sep 20237:00 amRNSFinal Results
31st Aug 20234:44 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 202311:52 amRNSHolding(s) in Company
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSTransaction in Own Shares
18th Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 202310:32 amRNSHolding(s) in Company
31st Jul 20234:41 pmRNSTotal Voting Rights
28th Jul 20237:00 amRNSResults of Secondary Placing in Darktrace
27th Jul 20236:31 pmRNSPlacing of Shares in Darktrace by Summit Partners
26th Jul 20237:00 amRNSLaunch of Darktrace HEAL™
24th Jul 20233:06 pmRNSDirector/PDMR Shareholding
24th Jul 20233:01 pmRNSTR-1: Notification of major holdings
19th Jul 20237:00 amRNSTransaction in Own Shares
18th Jul 20237:00 amRNSQ4 FY 2023 Trading Update
18th Jul 20237:00 amRNSConclusion of Ernst & Young LLP Review
18th Jul 20237:00 amRNSTransaction in Own Shares
17th Jul 20237:00 amRNSTransaction in Own Shares
14th Jul 20237:00 amRNSTransaction in Own Shares
13th Jul 20237:00 amRNSTransaction in Own Shares
12th Jul 20237:00 amRNSDirector/PDMR Shareholding
12th Jul 20237:00 amRNSTransaction in Own Shares
11th Jul 20237:00 amRNSTransaction in Own Shares
10th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20232:52 pmRNSIssue & Allotment of Shares & Total Voting Rights
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 20233:14 pmRNSIssue & Allotment of Shares & Total Voting Rights
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 202310:20 amRNSIssue & Allotment of Shares & Total Voting Rights
15th Jun 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.